ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 669 for:    Transient Ischemic Attack

Korean Transient Ischemic Attack eXpression Registry (KTX registry)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01870531
Recruitment Status : Completed
First Posted : June 6, 2013
Last Update Posted : June 9, 2015
Sponsor:
Information provided by (Responsible Party):
Yong-Seok Lee, Seoul National University Boramae Hospital

Brief Summary:
This study is to determine the clinical and neuroimaging characteristics of Transient Ischemic Attacks in Korean populations.

Condition or disease
Transient Ischemic Attack

Study Type : Observational [Patient Registry]
Actual Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 90 Days
Official Title: Transient Ischemic Attacks in Korean: Hospital-based, Multi-center Prospective Registry
Study Start Date : July 2010
Actual Primary Completion Date : March 2013
Actual Study Completion Date : August 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Vascular events including ischemic strokes, myocardial infarctions, cardiovascular deaths [ Time Frame: 90 days ]

Secondary Outcome Measures :
  1. Recurrent transient ischemic attacks [ Time Frame: 90 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
University Hospitals
Criteria

Inclusion Criteria:

  • Clinical symptoms and signs consistent with transient ischemic attack
  • Subject who admitted hospital within 24 hours after symptom onset
  • Subjects who underwent MRI (including diffusion-weighted images) and MRA (or CT angiography)

Exclusion Criteria:

Transient neurological symptoms due to

  • Migraine aura
  • Basilar migraine
  • Seizures
  • Syncope
  • Peripheral vertigo
  • Transient global amnesia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01870531


Locations
Korea, Republic of
Seoul National University Boramae Hospital
Seoul, Korea, Republic of, 156-707
Sponsors and Collaborators
Seoul National University Boramae Hospital
Investigators
Principal Investigator: Yong-Seok Lee, MD, PhD Seoul National University Boramae Hospital

Responsible Party: Yong-Seok Lee, Professor, Seoul National University Boramae Hospital
ClinicalTrials.gov Identifier: NCT01870531     History of Changes
Other Study ID Numbers: 800-20100046
First Posted: June 6, 2013    Key Record Dates
Last Update Posted: June 9, 2015
Last Verified: June 2015

Keywords provided by Yong-Seok Lee, Seoul National University Boramae Hospital:
Transient Ischemic Attack

Additional relevant MeSH terms:
Ischemia
Ischemic Attack, Transient
Pathologic Processes
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases